Fig. 3From: Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic miceCell viability of A primary murine bone marrow mesenchymal stem cells (mMSC) and B murine macrophages (Raw 264.7) after 24 h of treatment with the LPNPs suspensions at variable concentrations (1.41 mg/mL-0.1 µg/mL). (*) denotes statistical significance to control (non-treated cells) p < 0.05 (n = 3)Back to article page